Skip to content

Clinical trials

Phase 2 Esophageal Squamous Cell Carcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Phase 2 Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20181
20192
20214
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital5
BeiGene2
AstraZeneca1
Bayer1
Hoffmann-La Roche1
Ming-Yu Lien1
National Health Research Institutes, Taiwan1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma13
Esophageal Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Astrocytoma1
Carcinoma, Non-Small-Cell Lung1
Glioblastoma1
Melanoma1
Prostatic Neoplasms1
Small Cell Lung Carcinoma1
Uterine Cervical Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.